Hugh Brent Solvason PhD MD
Academic Appointments
- Associate Professor - Med Center Line, Psychiatry & Behavioral Science - Psychopharmacology
- Clinical Associate Professor, Psychiatry & Behavioral Science - Psychopharmacology
Key Documents
Contact Information
-
Clinical Offices
Psychiatry Department 401 Quarry Rd Ste 2138 MC 5723 Stanford, CA 94305 Tel Work (650) 723-8335 Fax (650) 723-8331
- Academic Offices
Personal Information Email Tel (650) 723-2749Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Psychiatry
- Electroconvulsive Therapy
- Transcranial Magnetic Stimulation
Administrative Appointments
- Medical Director, Interventional Psychiatric Therapies (2003 - 2010)
Honors and Awards
- Laughlin Fellow, American College of Psychiatrists (1997)
- George D Gulevic MD Award, Stanford Department of Psychiatry (June 21, 1997)
- Academic Teaching Award, Stanford Department of Psychiatry (June 18, 2001)
- Academic Teaching Award, San Mateo County Residency Training Program (June 15, 2003)
Professional Education
| Fellowship: | Stanford University School of Medicine CA (1998) |
| Doctorate Degree: | University of Alabama School of Medicine AL (1989) |
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (2001) |
| Residency: | Stanford University School of Medicine CA (1997) |
| PhD: | Univ Alabama at Birmingham, Cell and Molecular Biology (1989) |
| Internship: | Stanford University Medical Center CA (1994) |
Community and International Work
- Orphans and Vulnerable Children in Sub Saharan Africa, Zimbabwe, Namibia
Internet Links
Scientific Focus
Current Research Interests
My work is focused on novel interventional treatment approaches for treatment resistant unipolar and bipolar depression. We are currently enrolling patients with treatment refractory bipolar depression for a radiosurgical neuromodulation study. We are awaiting the start of enrollment for a DBS in unipolar depression study.
I am also working with children in Sub Saharan Africa. Primarily I am focused on methods to assess well-being, and long term outcomes for these vulnerable children.
Publications
- Coping with the challenges of living in an Indonesian residential institution. Health Policy. 2010; (1): 45-50
- Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial". Biol Psychiatry. 2010; (2): e15-7
- Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009; (11): 1178-88
- Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function. Psychoneuroendocrinology. 2009; (7): 1012-8
- Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial. Psychopharmacol Bull. 2008; (1): 34-45
- Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression. Am J Psychiatry. 2008; (7): 872-80
Help